Skip to content
Codrituzumab
Codrituzumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against glypican-3.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver neoplasmsD008113EFO_1001513C22.011———2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C801————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCODRITUZUMAB
INNcodrituzumab
Description
Codrituzumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against glypican-3.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL4298089
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDU9I0PLD4HT (ChemIDplus, GSRS)
Target
Agency Approved
GPC3
GPC3
Organism
Homo sapiens
Gene name
GPC3
Gene synonyms
OCI5
NCBI Gene ID
2719
Protein name
glypican-3
Protein synonyms
glypican proteoglycan 3, GTR2-2, heparan sulphate proteoglycan, Intestinal protein OCI-5, MXR7, secreted glypican-3
Uniprot ID
P51654
Mouse ortholog
Gpc3 (14734)
glypican-3 (Q8CFZ4)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 75 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details